2-[(4R)-4-[(1S,2S,5R,7R,10R,11S,14R,15R,16S)-5,16-dihydroxy-2,15-dimethyltetracyclo[8.7.0.02,7.011,15]heptadecan-14-yl]pentanamido]ethane-1-sulfonic acid

• ChemBase编号: 129714
• 分子式: C26H45NO6S
• 平均质量: 499.7036
• 单一同位素质量: 499.29675917
• SMILES: C[C@H](CCC(=O)NCCS(=O)(=O)O)[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]1[C@H]2CC[C@H]2[C@@]1(CC[C@H](C2)O)C)O)C
• Canonical SMILES: O[C@@H]1CC[C@]2([C@@H](C1)CC[C@@H]1[C@@H]2C[C@H](O)[C@]2([C@H]1CC[C@@H]2[C@@H](CCC(=O)NCCS(=O)(=O)O)C)C)C
• InChI: InChI=1S/C26H45NO6S/c1-16(4-9-24(30)27-12-13-34(31,32)33)20-7-8-21-19-6-5-17-14-18(28)10-11-25(17,2)22(19)15-23(29)26(20,21)3/h16-23,28-29H,4-15H2,1-3H3,(H,27,30)(H,31,32,33)/t16-,17-,18-,19+,20-,21+,22+,23+,25+,26-/m1/s1
• InChIKey: AWDRATDZQPNJFN-VAYUFCLWSA-N

名称和登记号

名称

• IUPAC标准名: 2-[(4R)-4-[(1S,2S,5R,7R,10R,11S,14R,15R,16S)-5,16-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0^2,^7.0^1^1,^1^5]heptadecan-14-yl]pentanamido]ethane-1-sulfonic acid
• IUPAC传统名: taurodeoxycholate
• 别名: Taurodeoxycholic acid; 2-[[(3α,5β,12β)-3,12-Dihydroxy-24-oxocholan-24-yl]amino]ethanesulfonic Acid; N-(3α,12α-Dihydroxy-5β-cholan-24-oyl)taurine; Deoxycholyltaurine; Deoxytaurocholic acid; Taurodesoxycholic Acid; Tudcabil; Taurodeoxychloic Acid Also See T009005

登记号

• CAS号: 516-50-7
• PubChem SID: 162224003
• PubChem CID: 2733768
• CHEBI ID: 9410
• CHEMBL: 412272
• Chemspider ID: 2015539
• 维基百科标题: Taurodeoxycholic_acid

理论计算性质

• Acid pKa: -0.94335264
• 质子受体: 6
• 质子供体: 4
• LogD (pH = 5.5): -0.14807612
• LogD (pH = 7.4): -0.14811489
• Log P: 0.84671533
• 摩尔折射率: 130.602 cm^3
• 极化性: 52.81067 Å^3
• 极化表面积: 123.93 Å^2
• 可自由旋转的化学键: 7
• 里宾斯基五规则: true

详细说明

Toronto Research Chemicals - T009000

Deoxycholyltaurine rescues human colon cancer cells from apoptosis by activating EGFR-dependent PI3K/Akt signaling.

参考文献

• Cheng, K., et al.: Biochem. J., 330, 353 (1998)
• Cheng, K., et al.: Cancer Res., 63, 6744 (1998)
• Bellacosa, A., et al.: Adv. Cancer Res., 94, 29 (1998)
• Cheng, K., et al.: Biochem. Pharmacol., 70, 1035 (1998)
• Fang, D., et al.: J. Biol. Chem., 282, 11221